Heart Failure With Preserved Ejection Fraction in Low‐Income Settings: Performance and Challenges of Screening Scores in a Population‐Based Cohort in Haiti
BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) is rapidly increasing in low- and middle-income countries, however detection remains challenging. We assessed 2 screening scores developed in high-income settings, H2FPEF and HFA-PEFF, against physician-adjudicated HFpEF in a population-based cohort from Haiti. METHODS: The primary outcome was prevalent HFpEF defined by (1) physician adjudication, (2) H2FpEF score, (3) HFA-PEFF score. The cross-sectional cohort comprised 3003 adults from the Haiti Cardiovascular Disease Cohort, with sociodemographic, clinical, electrocardiography, echocardiography and BNP data available. We compared physician-adjudicated HFpEF participants to those screening positive (intermediate-high H2FPEF and HFA-PEFF scores) using interrater reliability (Cohen's kappa, Krippendorff's alpha). Diagnostic performance of H2FPEF and HFA-PEFF against physician adjudication, used as a pragmatic reference standard appropriate for Haiti and similar settings, was calculated via sensitivity, specificity, and predictive values. RESULTS: Age-adjusted HFpEF prevalence was 9.5% (95% CI: 8.3-11.0) by physician adjudication, 10.2% (95% CI: 9.0-11.7) by H2FPEF, and 8.6% (95% CI: 7.5-10.0) by HFA-PEFF. Adjudicated HFpEF participants were young (median age 57), had high prevalence of hypertension (70%), obesity (33%), and no atrial fibrillation. Agreement between all 3 scores was moderate-substantial (alpha 0.57, 95% CI: 0.55-0.59), with the highest pair-wise agreement between physician adjudication and HFA-PEFF (kappa 0.62, 95% CI: 0.57-0.67). HFA-PEFF had higher sensitivity and similar specificity relative to H2FPEF. CONCLUSIONS: In this Haitian cohort, prevalent HFpEF occurred in relatively young participants with high hypertension and obesity rates and negligible atrial fibrillation. HFA-PEFF exhibited higher concordance and sensitivity than H2FPEF versus physician adjudication. Tailored, non-invasive HFpEF screening scores for low- and middle-income countries are needed to address this growing global epidemic.
Authors
- Gene F. Kwan (ORCID: https://orcid.org/0000-0002-0929-6800)
- Margaret L. McNairy (ORCID: https://orcid.org/0000-0001-7853-633X)
- Jean William Pape (ORCID: https://orcid.org/0000-0002-2948-2774)
- Alexandra Apollon
- Vanessa Rouzier (ORCID: https://orcid.org/0000-0002-9672-9474)
- Víctor G. Dávila‐Román (ORCID: https://orcid.org/0000-0001-8554-0011)
- Rodolphe Malebranche (ORCID: https://orcid.org/0000-0001-6385-9486)
- Wheytnie Alexandre (ORCID: https://orcid.org/0009-0005-8310-7093)
- C. W. Bennett (ORCID: https://orcid.org/0009-0003-2498-9941)
- Anju Ogyu (ORCID: https://orcid.org/0000-0002-7055-5509)
- Michel Théard
- Lily D. Yan (ORCID: https://orcid.org/0000-0001-6363-7920)
- Marie Deschamps (ORCID: https://orcid.org/0000-0001-6050-1606)
- Jean Pierre Brisma
- Maureen Ward (ORCID: https://orcid.org/0000-0001-8764-8333)
- Darby Marx
- Kelly Celestin
- Reichling St Sauveur
- Kevin Jerry G. Williams Macajou
- Kathryn Dupnik
Institutions
- Boston University (US)
- Washington University in St. Louis (US)
- University of Haiti (HT)
- Gheskio Centers (HT)
- Caribbean University (HT)
- Weill Cornell Medicine (US)
- Saint Louis University (US)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1161/jaha.126.049654
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Heart, Lung, and Blood Institute
- Fogarty International Center